Feb 28, 2019 / 01:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Novavax Prepare Trial Topline Results Call. (Operator Instructions) And as a reminder, today's conference call is being recorded. I'd now like to turn the conference over to Erika Trahan, Senior Manager of Investor and Public Relations. Please go ahead.
Erika S. Trahan - Novavax, Inc. - Senior Manager of Investor & Public Relations
Thank you, operator. Good morning. I would like to thank everyone for joining today's call to discuss the Prepare Trial Topline Results. A press release is currently available on our website at novavax.com and an audio archive of this conference call will be available on our website later today.
Joining me on today's call is Stan Erck; President and CEO of Novavax; and Dr. Gregory Glenn, President of Research & Development. Dr. Louis Fries, Chief Medical Officer; John Trizzino, Chief Business Officer and Chief Financial Officer; and Amy Fix, Senior Vice President of Regulatory Affairs will also be available for the Q&A portion of the call.
Before we
Novavax, Inc. - Special Call Transcript
Feb 28, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers